Suchen nach Schlagwort "Graft vs Host Disease"
Anzeige der Einträge 1-1 von 1
Acute graft-versus-host disease in thalassaemic marrow transplantation with low-dose antithymocyte globulin (1999)Our unit performed transplantations on 21 classes II and III thalassaemic patients [class II patients had either hepatomegaly or portal fibrosis and class III patients had both]. We used busulfan [15 mg/kg] and cyclophosphamide [200 mg/kg]. Graft-versus-host disease [GVHD] prophylaxis was cyclosporin, prednisolone and low-dose antithymocyte globulin. Our patient data showed a low incidence of acute GVHD following transplantation. We offer this regimen as an acceptable therapy for thalassaemic patients undergoing allogeneic marrow transplantation ...